Geode Capital Management’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-106,924
Closed -$10.7M – 4039
2015
Q1
$10.7M Buy
106,924
+32,612
+44% +$2.17M 0.01% 1334
2014
Q4
$3.9M Buy
74,312
+1,301
+2% +$38.2K ﹤0.01% 1978
2014
Q3
$1.87M Buy
73,011
+19,239
+36% +$409K ﹤0.01% 2395
2014
Q2
$1.2M Buy
53,772
+11,476
+27% +$251K ﹤0.01% 2690
2014
Q1
$1.3M Buy
+42,296
New +$1.14M ﹤0.01% 2612

Geode Capital Management's ASPX Position: Q2 2015 in Review

Geode Capital Management sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 106,924 shares — an estimated $10.7M sold.

Geode Capital Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $10.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Geode Capital Management reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Geode Capital Management sold 106,924 Auspex Pharmaceuticals shares in Q2 2015, an estimated $10.7M.
  • Geode Capital Management first reported a position in Auspex Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Geode Capital Management's Auspex Pharmaceuticals position peaked at $10.7M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.

Based on Geode Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.